Genetic testing company 23andMe, widely known for its at-home DNA testing kit, filed for bankruptcy and launched a sale process.

• Why it matters: Questions now emerge about the fate of the personal data of the 15 million customers who have used the company's services.

State of play: The bankruptcy filing came just weeks after 23andMe's board rejected a takeover offer from co-founder and CEO Anne Wojcicki.

• Wojcicki last night stepped down as CEO, but remains on the board and still hopes to buy the business, which went public via a SPAC in 2021.

Between the lines: There's no repeat incentive for consumers to keep testing their DNA, and the data 23andMe sold to drug developers wasn't proving valuable enough.

• "Additionally, over the past few years, consumer interest and demand for genetic testing kits declined," chief restructuring officer Matthew Kvarda said in a court filing.

What we're watching: Will people's personal data be sold off?

• 23andMe stresses, "Any buyer will be required to comply with applicable law with respect to treatment of customer data."
• A Sunday open letter from the company, however, notes that customers can still delete their data and account, which it says will "automatically opt you out of Research and discard your sample."

The bottom line: Customers can delete their 23andMe account within their account settings, according to the company's customer care page.

🕵️ The FBI confirmed the launch of a new task force in conjunction with the Bureau of Alcohol, Tobacco, Firearms and Explosives to investigate attacks targeting Tesla. (CNBC)

• The announcement came after police in Austin, Texas, said they were investigating several incendiary devices found at a Tesla dealership. (AP)

🚙 Hyundai will spend $5.8 billion to build an advanced steel plant in Louisiana, President Trump said today, part of a larger $21 billion U.S. investment by the South Korean industrial conglomerate. (Axios)

💉 Novo Nordisk agreed to pay up to $2 billion for the rights to China-based United Laboratories International's "triple-g" weight loss drug. The Ozempic and Wegovy maker will have the right to develop, manufacture and sell it if it comes to market. (MarketWatch)

Chinese automaker BYD is expected to surpass Tesla in EV sales this year — but it's already surpassed Tesla in total revenue.

• Why it matters: The two companies are the far-and-away global leaders in EV sales.

By the numbers: BYD today reported about $107 billion in 2024 revenue, topping Tesla's $98 billion for the first time.

• BYD — which already sells more vehicles than Tesla when plug-in hybrids are included — also recorded net income of about $5.6 billion.
• That's nearly 2.5x Tesla's profit for 2024.

The bottom line: Long gone are any doubts about which automaker is Tesla's biggest rival.

The fictional headquarters of the biotech company in the hit Apple TV+ series "Severance" has become a popular tourist destination.

• The big picture: The show's creators picked the Bell Works complex in Holmdel, New Jersey, as the ominous backdrop for Lumon Industries — the company revolutionizing work-life balance by severing those parts of people's lives through a simple, noninvasive brain procedure.

Zoom in: The building was once the "creative powerhouse" for the Bell Telephone Laboratories, AT&T's research arm, employing more than 15,000 people, per the New York Times.

• The building went into decline after the federal government settled antitrust cases that broke up AT&T's telecommunications monopoly.

The latest: It's now a mixed-used building with shops, a food court, a library and office space.